Canopy Growth (TSX:WEED) just revealed that its DOJA facility in Kelowna, British Columbia, has shifted exclusively to medical cultivation. The site will now provide small-batch craft cannabis tailored for Spectrum Therapeutics’ medical patient base, including Canadian veterans.
See our latest analysis for Canopy Growth.
After a volatile ride, Canopy Growth’s recent move toward medical cannabis crops comes amid renewed attention. Notably, the share price jumped 23% over the past 90 days, even as the one-year total shareholder return sits deep in negative territory. The latest pivot to craft cultivation for medical users hints at potential for a more stable foundation. However, long-term investors remain cautious given sharply negative five-year returns.
If this strategic shift got you curious, it might be a perfect moment to broaden your search and check out fast growing stocks with high insider ownership
With shares trading…
